Posttransplant adoptive immunotherapy with interleukin-2 in children suffering from neuroectodermal tumors with poor prognosis

Author： Kalwak K. Ussowicz M. Gorczynska E. Toporski J. Turkiewicz D. Boguslawska-Jaworska J. Chybicka A.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.34, Iss.2, 2002-03, pp. : 665-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allogeneic adoptive immunotherapy

By Tiberghien P. Robinet E. Ferrand C. Saas P. Herve P.

Transfusion Clinique et Biologique, Vol. 10, Iss. 3, 2003-05 ,pp. : 170-174

Elsevier

Access to resources Recommend Favorite

Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy

By Matsui K. O’Mara L.A. Allen P.M.

International Immunology, Vol. 15, Iss. 7, 2003-07 ,pp. : 797-805

Oxford University Press

Access to resources Recommend Favorite

Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation

By Bahr M.J. Rosenau J. Tietge U.J.F. Caselitz M. Hofmann M.W. Klempnauer J. Boker K.H.W. Strassburg C.P. Manns M.P.

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1493-1494

Elsevier

Access to resources Recommend Favorite

Effective anti-tumor adoptive immunotherapy: utilization of exogenous IL-2-independent cytotoxic T lymphocyte clones

By Iwashiro M.

International Immunology, Vol. 14, Iss. 12, 2002-12 ,pp. : 1459-1468

Oxford University Press

Access to resources Recommend Favorite

Reprogramming donor T cells for adoptive immunotherapy

By Mapara Markus Y

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1287-1289

Future Medicine

Access to resources Recommend Favorite